Davidson Kempner Capital Management »

Maze Therapeatics shares owned by Davidson Kempner Capital Management

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Davidson Kempner Capital Management from 13F filings

Historical chart of Davidson Kempner Capital Management investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Davidson Kempner Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Davidson Kempner Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $151k 14k 11.01

More positions owned by Davidson Kempner Capital Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Verona Pharma Sponsored Ads (VRNA)
Seagate Hdd Cayman Note 3.500% 6/0 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Pdd Holdings Note 12/0 (Principal)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Uber Technologies Note 0.875%12/0 (Principal)
Jd.com Note 0.250% 6/0 (Principal)
Amazon (AMZN)
Arko Corp (ARKO)
Rivian Automotive Note 4.625% 3/1 (Principal)
Redfin Corp Note 0.500% 4/0 (Principal)
NVIDIA Corporation (NVDA)
Snowflake Note 10/0 (Principal)

View all positions for Davidson Kempner Capital Management

Top funds holding Maze Therapeatics

Trv Gp Iv
Frazier Life Sciences Management
Arch Venture Corp
Deep Track Capital
Alphabet
AH Capital Management
Matrix Capital Management Company
Vanguard Group
BlackRock
VR Adviser
Logos Global Management
General Catalyst Group Management
Woodline Partners
TRV GP V
Marshall Wace

View all funds holding Maze Therapeatics